ALK and mature T-cell and NK-cell non-Hodgkin lymphoma: In the NLG-T-01 study, the largest prospective study of PTCL patients (excluding ALK + ALCL patients) receiving consolidative ASCT, a total of 160 patients were enrolled and 115 completed the induction therapy with CHOEP followed by ASCT [7].